Quarterly report pursuant to Section 13 or 15(d)

Schedule of Share-based Compensation, Stock Options, Activity (Details)

v3.22.2.2
Schedule of Share-based Compensation, Stock Options, Activity (Details)
$ / shares in Units, $ in Thousands
 9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Option Indexed to Issuer's Equity [Line Items]  
Total Options Outstanding, Granted 158,000
Share-Based Payment Arrangement, Option [Member]  
Option Indexed to Issuer's Equity [Line Items]  
Number of Shares Available for Grant, Beginning 629,000
Total Options Outstanding, Beginning 206,000
Weighted Average Exercise Price Outstanding, Beginning | $ / shares $ 23.76
Aggregate Intrinsic Value, Beginning | $
Number of Shares Available for Grant, Increase in authorized options
Total Options Outstanding, Increase in authorized options
Weighted Average Exercise Price, Increase in authorized options | $ / shares
Aggregate Intrinsic Value, Increase in authorized options | $
Number of Shares Available for Grant, Exercised
Total Options Outstanding, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Aggregate Intrinsic Value, Exercised | $
Number of Shares Available for Grant, Granted (158,000)
Total Options Outstanding, Granted 158,000
Weighted Average Exercise Price, Granted | $ / shares $ 5.04
Aggregate Intrinsic Value, Granted | $ / shares
Number of Shares Available for Grant, Expired 12,000
Total Options Outstanding, Expired (13,000)
Weighted Average Exercise Price, Expired | $ / shares $ 33.24
Aggregate Intrinsic Value, Expired | $
Number of Shares Available for Grant, Cancelled 1,000
Total Options Outstanding, Cancelled (1,000)
Weighted Average Exercise Price, Cancelled | $ / shares $ 15.36
Aggregate Intrinsic Value, Cancelled | $ $ 9
Number of Shares Available for Grant, Ending 484,000
Total Options Outstanding, Ending 350,000
Weighted Average Exercise Price, Ending | $ / shares $ 15.36
Aggregate Intrinsic Value, Ending | $ $ 9